Current stage-Stage III Posts on Medivizor
Navigation Menu

Current stage-Stage III Posts on Medivizor

X-ray brachytherapy might be a safer option in the treatment of early rectal cancers

Posted by on Mar 20, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effect of X-ray brachytherapy (XRB) in the treatment of patients with rectal cancer who underwent local surgery. Researchers suggested that XRB is associated with improved outcomes and could be used instead of radical surgery. Some background Screening programs increased the number of patients being diagnosed...

Read More

TVEC therapy for patients with advanced stage melanoma

Posted by on Mar 5, 2019 in Melanoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of talimogene laherparepvec (TVEC) therapy for patients with melanoma that cannot be surgically removed (unresectable). The study found that TVEC therapy is an effective treatment for these patients, with minimal side effects. Some background Patients with localized melanoma that is...

Read More

Transanal endoscopic microsurgery after chemoradiotherapy improves rectal cancer outcomes

Posted by on Feb 28, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated long term rectal cancer outcomes in patients who received chemotherapy, radiation therapy, and transanal microsurgery. Researchers suggested that this treatment improves treatment outcomes and quality of life of patients. Some background The standard treatment for rectal cancer is surgery. However,...

Read More

Survival in patients with melanoma treated with pembrolizumab

Posted by on Feb 20, 2019 in Melanoma | 0 comments

In a nutshell This study wanted to find out what the survival rates are of patients with melanoma treated with pembrolizumab (Keytruda). The study found that after 5 years, there was a good response to treatment overall. Some background Pembrolizumab is a new cancer treatment. It treats many different types of cancer. It works by using the immune...

Read More

Chemotherapy and radiation therapy are safe options before surgery in elderly patients with rectal cancer

Posted by on Feb 13, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of chemotherapy and radiation therapy (CRT) with capecitabine (Xeloda) before surgery in elderly patients with locally advanced rectal cancer. Researchers suggested that this treatment is safe and well tolerated in the elderly. Some background Colorectal cancer is the third most commonly...

Read More

Joint pain and falls among women with breast cancer on aromatase inhibitors.

Posted by on Jan 18, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if joint pain is associated with falling down in patients with breast cancer who were treated with aromatase inhibitors. The study found that the patients who reported having joint pain were more likely to have a fall than those who had no joint pain. Some background Aromatase inhibitors are medications...

Read More

Adding everolimus to endocrine therapy in patients with HER2- ER+ advanced breast cancer

Posted by on Jan 5, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if treating breast cancer with everolimus (Afintor) and endocrine therapy is better than only treating with endocrine therapy. The study found that using everolimus in addition to endocrine therapy had a significant benefit to survival in these patients. Some background Breast cancer is classified into types...

Read More

Adding ixabepilone to capecitabine treatment for triple negative breast cancer.

Posted by on Dec 11, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if ixabepilone (Ixempra) and capecitabine (Xeloda) work for treating triple-negative breast cancer in patients with hard to treat disease compared to using capecitabine alone. The study found that adding ixabepilone to treatment resulted in longer survival without the cancer progressing. Some background...

Read More